BioWorld MedTech

March 23, 2016

View Archived Issues

Sequenom seeks cert in scrum with Ariosa over the '540 patent

New self-confirming assay addresses the 'seroconversion' window

Boston Sci launches Axios system to treat pancreatitis complications

Fi nancings

Daily M&A

Product briefs

Oncology Extra

MIT polymer raises $25 million in early stage deal for Gecko Biomedical

PARIS – Would you pay $25 million to come in on the ground floor of Super Glue? Read More

GERD is the word: Treatment of esophageal disorders in spotlight

Today's news in brief

BioWorld

Precision psychiatry beyond, or before, biomarkers

BioWorld

There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...

ADPD 2026: Can we prevent dementia? Scientists quantify it

BioWorld

Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...

First-in-class POLG activator restores mtDNA across mutations

BioWorld Science

Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...

News in brief

BioWorld Asia

BioWorld Asia briefs for March 17, 2026